Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000594362 | SCV000709307 | uncertain significance | not provided | 2017-06-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001312485 | SCV001502941 | likely benign | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2024-06-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004024856 | SCV004918754 | uncertain significance | Inborn genetic diseases | 2024-01-23 | criteria provided, single submitter | clinical testing | The c.3643A>G (p.S1215G) alteration is located in exon 30 (coding exon 28) of the CC2D2A gene. This alteration results from a A to G substitution at nucleotide position 3643, causing the serine (S) at amino acid position 1215 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005034179 | SCV005664556 | uncertain significance | Meckel syndrome, type 6; Joubert syndrome 9; COACH syndrome 2; Retinitis pigmentosa 93 | 2024-04-09 | criteria provided, single submitter | clinical testing |